Back to results

$35M QVAR antitrust class action settlement

via Top Class Actions Published: Jun 02, 2026

Summary

Teva Pharmaceuticals agreed to pay $35 million to resolve claims it engaged in antitrust behavior to keep its QVAR asthma medication from facing generic competition.... Read More The post $35M QVAR antitrust class action settlement appeared first on Top Class Actions.

Read full article →